Enovis Corp (ENOV)

$26.95 -2.73 (-9.20%)
Market Cap 1.70B
Revenue (ttm) 2.11B
Net Income (ttm) -825.49M
EPS (ttm) N/A
PE Ratio 8.91
Forward PE 8.86
Profit Margin -39.17%
Debt to Equity Ratio 0.67
Volume 1,844,800
Avg Vol 913,594
Day's Range N/A - N/A
Shares Out 57.19M
Stochastic %K 19%
Beta 1.52
Analysts Strong Sell
Price Target $45.50

Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic sho...

Industry: Medical Devices
Sector: Healthcare
Phone: 302 252 9160
Address:
2711 Centerville Road, Suite 400, Wilmington, United States
NakedDayTrader4
NakedDayTrader4 Jan. 12 at 8:07 PM
$ENOV they raised earnings estimates but lowered top line revs..and it’s down 9%?! 🤣 down that mean their margins are rising?
0 · Reply
momyurich
momyurich Jan. 12 at 4:55 PM
$ENOV initiated 👍📈
0 · Reply
momyurich
momyurich Jan. 7 at 3:52 PM
$ENOV 👍📈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 1 at 12:54 PM
$ENOV RSI: 43.70, MACD: -0.5630 Vol: 0.71, MA20: 27.16, MA50: 29.13 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:14 PM
Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 58 → 50.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:04 PM
Freedom Capital Markets updates rating for Enovis ( $ENOV ) to Buy, target set at 45.
0 · Reply
stockRDA
stockRDA Dec. 13 at 6:25 PM
$ENOV 89 watchers here lol. I’m expecting $35-$38. $MDT could be a potential acquirer.
0 · Reply
stockRDA
stockRDA Dec. 8 at 1:09 AM
$ENOV 15% pop once Supreme Court rules tariffs are illegal…
0 · Reply
stockRDA
stockRDA Dec. 7 at 9:29 PM
$ENOV valuation is low here compared to peers. I’m expecting $40
0 · Reply
stockRDA
stockRDA Dec. 5 at 8:20 PM
$ENOV i smell a buy out…..
0 · Reply
Latest News on ENOV
Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 12:55 AM EST - 5 hours ago

Enovis Corporation (ENOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 7:30 AM EST - 4 days ago

Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Enovis Appoints Oliver Engert as Chief Administrative Officer

Jan 5, 2026, 4:15 PM EST - 7 days ago

Enovis Appoints Oliver Engert as Chief Administrative Officer

Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 10, 2025, 5:31 PM EST - 2 months ago

Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript

Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:26 PM EST - 2 months ago

Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript

Enovis Announces Third Quarter 2025 Results

Nov 6, 2025, 6:01 AM EST - 2 months ago

Enovis Announces Third Quarter 2025 Results

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

Oct 24, 2025, 4:11 PM EDT - 2 months ago

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million

Oct 8, 2025, 8:15 AM EDT - 3 months ago

Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Sep 8, 2025, 4:05 PM EDT - 4 months ago

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Enovis: Healthy Recon Trends Vs. Market Apathy

Aug 27, 2025, 8:24 AM EDT - 4 months ago

Enovis: Healthy Recon Trends Vs. Market Apathy

Enovis to Participate in Upcoming Investor Conferences

Aug 8, 2025, 9:00 AM EDT - 5 months ago

Enovis to Participate in Upcoming Investor Conferences

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:25 AM EDT - 5 months ago

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Enovis Announces Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 5 months ago

Enovis Announces Second Quarter 2025 Results

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Jul 8, 2025, 4:05 PM EDT - 6 months ago

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

May 26, 2025, 10:46 AM EDT - 8 months ago

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

May 11, 2025, 1:46 AM EDT - 8 months ago

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

Enovis Announces First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 8 months ago

Enovis Announces First Quarter 2025 Results

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Apr 17, 2025, 7:00 AM EDT - 9 months ago

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Apr 2, 2025, 6:30 AM EDT - 10 months ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Mar 25, 2025, 8:00 AM EDT - 10 months ago

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Enovis Continues To Languish Despite Decent Financial Results

Feb 28, 2025, 8:23 AM EST - 11 months ago

Enovis Continues To Languish Despite Decent Financial Results

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 12:53 PM EST - 11 months ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:01 AM EST - 11 months ago

Enovis Announces Fourth Quarter and Full Year 2024 Results

Enovis Announces Planned CEO Succession Process

Feb 26, 2025, 6:00 AM EST - 11 months ago

Enovis Announces Planned CEO Succession Process

Enovis™ Announces Leadership Change to International Surgical Business

Jan 17, 2025, 6:00 AM EST - 1 year ago

Enovis™ Announces Leadership Change to International Surgical Business

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Jan 7, 2025, 6:19 PM EST - 1 year ago

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:15 PM EST - 1 year ago

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Enovis Corporation: Reasonably Valued With Caveats

Nov 22, 2024, 12:17 PM EST - 1 year ago

Enovis Corporation: Reasonably Valued With Caveats

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 12:50 PM EST - 1 year ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Enovis Announces Third Quarter 2024 Results

Nov 6, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2024 Results

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Oct 3, 2024, 3:39 PM EDT - 1 year ago

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Sep 9, 2024, 3:50 PM EDT - 1 year ago

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Aug 20, 2024, 8:00 AM EDT - 1 year ago

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Enovis Announces Second Quarter 2024 Results

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Jul 25, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Jul 16, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Enovis Languishing Despite Respectable Performance

Jul 15, 2024, 12:58 AM EDT - 1 year ago

Enovis Languishing Despite Respectable Performance

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Jul 12, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Top 3 Health Care Stocks That Could Blast Off In June

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

May 2, 2024, 2:24 PM EDT - 1 year ago

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

Enovis Announces First Quarter 2024 Results

May 2, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces First Quarter 2024 Results

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Apr 17, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 12:14 PM EST - 2 years ago

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 6:00 AM EST - 2 years ago

Enovis Announces Fourth Quarter and Full Year 2023 Results

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Feb 12, 2024, 11:30 AM EST - 2 years ago

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 7, 2024, 4:15 PM EST - 2 years ago

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Jan 26, 2024, 6:00 AM EST - 2 years ago

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Jan 25, 2024, 8:30 AM EST - 2 years ago

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

NakedDayTrader4
NakedDayTrader4 Jan. 12 at 8:07 PM
$ENOV they raised earnings estimates but lowered top line revs..and it’s down 9%?! 🤣 down that mean their margins are rising?
0 · Reply
momyurich
momyurich Jan. 12 at 4:55 PM
$ENOV initiated 👍📈
0 · Reply
momyurich
momyurich Jan. 7 at 3:52 PM
$ENOV 👍📈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 1 at 12:54 PM
$ENOV RSI: 43.70, MACD: -0.5630 Vol: 0.71, MA20: 27.16, MA50: 29.13 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:14 PM
Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 58 → 50.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:04 PM
Freedom Capital Markets updates rating for Enovis ( $ENOV ) to Buy, target set at 45.
0 · Reply
stockRDA
stockRDA Dec. 13 at 6:25 PM
$ENOV 89 watchers here lol. I’m expecting $35-$38. $MDT could be a potential acquirer.
0 · Reply
stockRDA
stockRDA Dec. 8 at 1:09 AM
$ENOV 15% pop once Supreme Court rules tariffs are illegal…
0 · Reply
stockRDA
stockRDA Dec. 7 at 9:29 PM
$ENOV valuation is low here compared to peers. I’m expecting $40
0 · Reply
stockRDA
stockRDA Dec. 5 at 8:20 PM
$ENOV i smell a buy out…..
0 · Reply
stockRDA
stockRDA Dec. 1 at 9:17 PM
$ENOV I smell a buyout……..
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:51 PM
Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 41 → 42.
0 · Reply
d_risk
d_risk Nov. 6 at 4:12 PM
$ENOV - Enovis Corporation Common Stock - 10Q - Updated Risk Factors ENOV warns that further impairment of intangible assets, including goodwill, could hit operating results and total capitalization. #HealthcareSector #CapitalizationRisk #OperatingResultsImpact #GoodwillRisk #IntangibleAssetImpairment 🟢 Added 🟠 Removed https://d-risk.ai/ENOV/10-Q/2025-11-06
0 · Reply
DonCorleone77
DonCorleone77 Nov. 6 at 11:35 AM
$ENOV Enovis reports Q3 adjusted EPS 75c, consensus 65c -- Q3 revenue $549M, consensus $538.61M. -- Raises FY25 adjusted EPS view to $3.10-$3.25 from $3.05-$3.20, consensus $3.13.
0 · Reply
nikitatrades
nikitatrades Oct. 15 at 9:03 AM
💼 Enovis $ENOV sells its Dr. Comfort diabetic shoe business for up to $60M. The divestiture allows the company to sharpen its focus on its core Prevention & Recovery segment.
0 · Reply
stockRDA
stockRDA Oct. 11 at 1:51 AM
$ENOV good cheap company. Will buy more if this name drops next week.
0 · Reply
nikitatrades
nikitatrades Oct. 8 at 8:00 PM
Strategic move for $ENOV: 💼 Sells Dr. Comfort business for up to $60M. Sharpens focus on core Prevention & Recovery. Enhances margins and accelerates debt paydown.
0 · Reply
jabber621
jabber621 Sep. 22 at 5:07 PM
$ENOV can someone remind why I am invested here?
0 · Reply
RalphThomas530
RalphThomas530 Sep. 21 at 11:01 AM
$ENOV Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum.
0 · Reply
stockRDA
stockRDA Sep. 18 at 12:40 AM
$ENOV anybody here? I like this business.
0 · Reply
SocioCobb
SocioCobb Sep. 12 at 3:29 AM
$ENOV
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Sep. 12 at 12:05 AM
$ENOV CEO purchased 6,457 shares at $30.97 for a total of $199,973. McDonald Damien now owns 102,753 shares. https://ceo-buys.com
0 · Reply